搜尋
Connect Biopharma Holdings Ltd
CNTB添加自選
1.070USD
-0.145-11.93%
收盤 09-23 16:00（美東）
59.62M總市值
虧損本益比TTM
盤前交易 08:14 (美東)1.095USD+0.025+2.34%
盤前交易 08:14 (美東)關於 Connect Biopharma Holdings Ltd 公司
Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company. The Company is focused on advancing rademikibart, a potentially best-in-class next generation anti-interleukin-4-receptor alpha (IL-4Rα) antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease (COPD). Its lead product candidate, rademikibart, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα) in development for the treatment of atopic dermatitis (AD) and asthma. As an inhibitor of IL-4Rα, rademikibart blocks inflammatory signaling by both IL-4 and IL-13. The Company has completed a global Phase II trial (CBP-201-WW001) of rademikibart in adult patients with moderate-to-severe AD.
Connect Biopharma Holdings Ltd 簡介
公司代碼CNTB
公司名稱Connect Biopharma Holdings Ltd
上市日期Mar 19, 2021
CEOQuart (Barry D)
員工數量62
證券類型Ordinary Share
年結日Mar 19
公司地址3580 Carmel Mountain Road, Suite 200
城市SAN DIEGO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編92130
電話18587271040
網址https://www.connectbiopharm.com
公司代碼CNTB
上市日期Mar 19, 2021
CEOQuart (Barry D)
Connect Biopharma Holdings Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Barry D. Quart, Pharm.D.
Dr. Barry D. Quart, Pharm.D.
Chief Executive Officer and Director
Chief Executive Officer and Director
224.03K
+41.13%
Dr. Barry D. Quart, Pharm.D.
Dr. Barry D. Quart, Pharm.D.
Chief Executive Officer and Director
Chief Executive Officer and Director
224.03K
+41.13%
Dr. Barry D. Quart, Pharm.D.
Dr. Barry D. Quart, Pharm.D.
Chief Executive Officer and Director
Chief Executive Officer and Director
224.03K
+41.13%
Dr. Kleanthis G. Xanthopoulos, Ph.D.
Dr. Kleanthis G. Xanthopoulos, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
86.55K
+4.32%
Dr. Kleanthis G. Xanthopoulos, Ph.D.
Dr. Kleanthis G. Xanthopoulos, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
86.55K
+4.32%
Dr. Kleanthis G. Xanthopoulos, Ph.D.
Dr. Kleanthis G. Xanthopoulos, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
86.55K
+4.32%
Ms. Lisa Peraza, CPA
Ms. Lisa Peraza, CPA
Vice President - Finance
Vice President - Finance
45.19K
--
Ms. Lisa Peraza, CPA
Ms. Lisa Peraza, CPA
Vice President - Finance
Vice President - Finance
45.19K
--
Ms. Lisa Peraza, CPA
Ms. Lisa Peraza, CPA
Vice President - Finance
Vice President - Finance
45.19K
--
Dr. Jean I. Liu, J.D.
Dr. Jean I. Liu, J.D.
Independent Director
Independent Director
11.78K
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Barry D. Quart, Pharm.D.
Dr. Barry D. Quart, Pharm.D.
Chief Executive Officer and Director
Chief Executive Officer and Director
224.03K
+41.13%
Dr. Barry D. Quart, Pharm.D.
Dr. Barry D. Quart, Pharm.D.
Chief Executive Officer and Director
Chief Executive Officer and Director
224.03K
+41.13%
Dr. Barry D. Quart, Pharm.D.
Dr. Barry D. Quart, Pharm.D.
Chief Executive Officer and Director
Chief Executive Officer and Director
224.03K
+41.13%
Dr. Kleanthis G. Xanthopoulos, Ph.D.
Dr. Kleanthis G. Xanthopoulos, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
86.55K
+4.32%
Dr. Kleanthis G. Xanthopoulos, Ph.D.
Dr. Kleanthis G. Xanthopoulos, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
86.55K
+4.32%
Dr. Kleanthis G. Xanthopoulos, Ph.D.
Dr. Kleanthis G. Xanthopoulos, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
86.55K
+4.32%
常見問題
Connect Biopharma Holdings Ltd的前五大股東是誰？
Connect Biopharma Holdings Ltd的前五大股東如下：Dr. Barry D. Quart, Pharm.D.
有多少機構持有Connect Biopharma Holdings Ltd(CNTB)的股份？
截至2026Q1，共有51家機構持有Connect Biopharma Holdings Ltd的股份，合計持有的股份價值約為29.94M，占公司總股份的52.97% 。與2025Q4相比，機構持股有所增加，增幅為8109973.00。